22 May 2013
Keywords: tkt, settles, gene, therapy, patent, case, transkaryotic
Article | 25 March 2002
Transkaryotic Therapies has reached a settlement in gene therapy patentinterferences involving Genetic Therapy (a subsidiary of Novartis),
Syntex (a US ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 March 2002
21 May 2013
© 2013 thepharmaletter.com